The German pharmaceutical-and-agricultural group said the acquisition would complement its drug pipeline and leverage its ophthalmology footprint.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Date:
More like thisRelated
City of Albuquerque hosts annual Freedom Fourth fireworks event at Balloon Fiesta Park
ALBUQUERQUE, N.M. (KRQE) – It's the Fourth of July, which...
EV Batteries Are Defying Expectations After Hundreds of Thousands of Miles
Industry experts think newfound knowledge of battery durability is...